A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals

Nutrition Reviews

Volumn 65, Issue 6, 2007, Pages 259-267

  Minich, Deanna M ^a   Bland, Jeffrey S ^a  

^a Metagenics Inc   (United States)

Author keywords

16 hydroxyestrone; 2 hydroxyestrone; 3,3 diindolylmethane; Cruciferous vegetables; Indole 3 carbinol

Indexed keywords

3 INDOLEMETHANOL; 3,3' DIINDOLYLMETHANE; ESTROGEN; PLANT MEDICINAL PRODUCT; 3,3'-DIINDOLYLMETHANE; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; INDOLE-3-CARBINOL; PHYTOESTROGEN; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; BREAST CANCER; BRONCHOSPASM; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG SAFETY; ESTROGEN METABOLISM; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL PAIN; HOT FLUSH; HUMAN; LUNG TUMOR; RASH; REVIEW; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VULVA TUMOR; BRASSICACEAE; CHEMISTRY; METABOLISM; NEOPLASM; RISK FACTOR; SAFETY; VEGETABLE;

ANTICARCINOGENIC AGENTS; BRASSICACEAE; CONSUMER PRODUCT SAFETY; HUMANS; INDOLES; NEOPLASMS; PHYTOESTROGENS; RISK FACTORS; VEGETABLES;

EID: 34547180025     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2007.jun.259-267     Document Type: Review

References (51)

1. Verhagen H., Poulsen HE, Loft S., van Poppel G., Willems MI, van Bladeren PJ. Reduction of oxidative DNA-damage in humans by brussels sprouts. Car-cinogenesis 1995 16 : 969 970.
2. von Poppel G., Verhoeven DT, Verhagen H., Gold-bohm RA. Brassica vegetables and cancer prevention. Epidemiology and mechanisms. Adv Exp Med Biol 1999 472 : 159 168.
3. Terry P., Wolk A., Persson I., Magnusson C. Brassica vegetables and breast cancer risk. JAMA 2001 285 : 2975 2977.
4. Keck AS, Finley JW. Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and selenium. Integr Cancer Ther 2004 3 : 5 12.
5. Grubbs CJ, Steele VE, Casebolt T., et al. Chemopre-vention of chemically-induced mammary carcino-genesis by indole-3-carbinol. Anticancer Res 1995 15 : 709 716.
6. Kojima T., Tanaka T., Mori H. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 1994 54 : 1446 1449.
7. Yuan F., Chen DZ, Liu K., Sepkovic DW, Bradlow HL, Auborn K. Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer. Anticancer Res 1999 19 : 1673 1680.
8. Johnson IT. Glucosinolates: bioavailability and importance to health. Int J Vitam Nutr Res 2002 72 : 26 31.
9. De Kruif CA, Marsman JW, Venekamp JC, et al. Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chem Biol Interact 1991 80 : 303 315.
10. Bradfield CA, Bjeldanes LF. Structure-activity relationships of dietary indoles: A proposed mechanism of action as modifiers of xenobiotic metabolism. J Toxicol Environ Health 1987 21 : 311 323.
11. Grose KR, Bjeldanes LF. Oligomerization of indole3-carbinol in aqueous acid. Chem Res Toxicol 1992 5 : 188 193.
12. Liu H., Wormke M., Saffe SH, Bjeldanes LF. In-dolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J Natl Cancer Inst 1994 86 : 1758 1765.
13. Riby JE, Feng C., Chang Y-C, Schaldach CM, Firestone GL, Bjeldanes LF. The major cyclic trimeric product of indole-3-carbinol is a strong agonist of the estrogen receptor signaling pathway. Biochem 2000 39 : 910 918.
14. Benabadji SH, Wen R., Zheng JB, Dong XC, Yuan SG. Anticarcinogenic and antioxidant activity of diindolylmethane derivatives. Acta Pharmacol Sin 2004 25 : 666 671.
15. Firestone GL, Bjeldanes LF. Indole-3-carbinol and 3-3′- diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J Nutr 2003 133 : 2448S 2455S.
16. Nachshon-Kedmi M., Yannai S., Haj A., Fares FA. Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 2003 41 : 745 752.
17. Hong C., Kim HA, Firestone GL, Bjeldanes LF. 3,3′-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 2002 23 : 1297 1305.
18. Sepkovic DW, Bradlow HL, Bell M. Quantitative determination of 3,3′-diindolylmethane in urine of individuals receiving indole-3-carbinol. Nutr Cancer 2001 41 : 57 63.
19. Balk JL. Indole-3-carbinol for cancer prevention. Alt Med Alert 2000 3 : 105 107.
20. National Toxicology Program. Department of Health and Human Services. Background Information: In-dole-3-Carbinol (I3C), 700-06-1, June 28, 2000. Available at :. Accessed April 30, 2007.
21. Chang YC, Riby J., Chang GH, Peng BC, Firestone G., Bjeldanes LF. Cytostatic and antiestrogenic effects of 2-(indole-3-ylmethyl)-3,3′- diindolylmeth-ane, a major in vivo product of dietary indole-3-carbinol. Biochem Pharmacol 1999 58 : 825 834.
22. Stresser DM, Williams DE, Griffin DA, Bailey GS. Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats. Drug Metab Dispos 1995 23 : 965 975.
23. Anderton MJ, Manson MM, Verschoyle RD, et al. Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin Cancer Res 2004 10 : 5233 5241.
24. MeSH Browser. National Library of Medicine. Avail able at :. entrez/query.fcgi?db=mesh. Accessed: April 30, 2007.
25. Wong GY, Bradlow L., Sepkovic D., Mehl S., Mailman J., Osborne MP. Dose-ranging study of indole-3-carbinol for breast cancer prevention. J Cell Bio-chem Suppl 1997 28-29 : 111 116.
26. Bell MC, Crowley-Nowick P., Bradlow HL, et al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 2000 78 : 123 129.
27. Naik R., Nixon S., Lopes A., Godfrey K., Hatem MH, Monaghan JM. A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia. Int J Gynecol Cancer 2006 16 : 786 790.
28. Taioli E., Bradlow HL, Garbers SV, et al. Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk. Cancer Detect Prev 1999 23 : 232 237.
29. Rosen CA, Bryson PC. Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice 2004 18 : 248 253.
30. Rosen CA, Woodson GE, Thompson JW, Henge-steg AR, Bradlow HL. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 1998 118 : 810 815.
31. de Bilderling G., Bodart E., Lawson G., et al. Successful use of intralesional and intravenous Cidofovir in association with indole-3-carbinol in an 8 year-old girl with pulmonary papillomatosis. J Med Virol 2005 75 : 332 335.
32. McAlindon TE, Gulin J., Chen T., Klug T., Lahita R., Nuite M. Indole-3-carbinol in women with SLE: effect on estrogen metabolism and disease activity. Lupus 2001 10 : 779 783.
33. Reed GA, Peterson KS, Smith HJ, et al. A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev 2005 14 : 1953 1960.
34. Michnovicz JJ. Increased estrogen 2-hydroxylation in obese women using oral indole-3-carbinol. Int J Obes Relat Metab Disord 1998 22 : 227 229.
35. Michnovicz JJ, Adlercreutz H., Bradlow HL. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J Natl Cancer Inst 1997 89 : 718 723.
36. Bradlow HL, Michnovicz JJ, Halper M., Miller DG, Wong GY, Osborne MP. Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol Biomarkers Prev 1994 3 : 591 595.
37. Michnovicz JJ, Bradlow HL. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr Cancer 1991 16 : 59 66.
38. Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF. Pilot study: effect of 3,3′-diin-dolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer 2004 50 : 161 167.
39. Indole-3-Carbinol. Monograph. Altern Med Rev 2005 10 : 337 342.
40. Schneider J., Huh MM, Bradlow HL, Fishman J. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 1984 259 : 4840 4845.
41. Suto A., Bradlow HL, Wong GY, Osborne MP, Tel-ang NT. Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Res Treat 1993 27 : 193 202.
42. Ho GH, Luo XW, Ji CY, Foo SC, Ng EH. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. Ann Acad Med Singapore 1998 27 : 294 299.
43. Muti P., Bradlow HL, Micheli A., et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 2000 11 : 635 640.
44. Fowke JH, Qi D., Bradlow HL, et al. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection. Steroids 2003 68 : 65 72.
45. Kabat GC, O'Leary ES, Gammon MD, et al. Estrogen metabolism and breast cancer. Epidemiology 2006 17 : 80 88.
46. Tsuchiya Y., Nakajima M., Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 2005 227 : 115 24.
47. Cavalieri E., Frenkel K., Liehr JG, Rogan E., Roy D. Estrogens as endogenous genotoxic agents - DNA adducts and mutations. J Natl Cancer Inst Monogr 2000 27 : 75 93.
48. Shertzer HG, Senft AP. The micronutrient indole-3-carbinol: implications for disease and chemoprevention. Drug Metabol Drug Interact 2000 17 : 159 188.
49. Stoewsand GS, Anderson JL, Munson L. Protective effect of dietary brussels sprouts against mammary carcinogenesis in Sprague-Dawley rats. Cancer Lett 1988 39 : 199 207.
50. Telang NT, Katdare M., Bradlow HL, Osborne MP, Fishman J. Inhibition of proliferation and modulation of estradiol metabolism: novel mechanisms for breast cancer prevention by the phytochemical in-dole-3-carbinol. Proc Soc Exp Biol Med 1997 216 : 246 252.
51. Zeligs MA. Diet and estrogen status: the cruciferous connection. J Med Food 1998 1 : 67 81.